微笑: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSCCC(O)=O)O[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H]5O[C@@H]9CSCCC(O)=O)O[C@@H]8CSCCC(OC[C@@H]%10[C@@H](O[C@@H]%11[C@H](O)[C@@H](O)[C@H](O%12)[C@@H](CSCCC(O)=O)O%11)[C@H](O)[C@@H](O)[C@@H](O[C@H]%13[C@H](O)[C@@H](O)[C@@H](O[C@H]%14[C@H](O)[C@@H](O)[C@@H](O[C@H]%15[C@H](O)[C@@H](O)[C@@H](O[C@@H]%16[C@@H](CSCCC(O)=O)O[C@H](O[C@H]%17[C@H](O)[C@@H](O)[C@@H](O[C@H]%18[C@H](O)[C@@H](O)[C@@H]%12O[C@@H]%18CSCCC(O)=O)O[C@@H]%17CSCCC(O)=O)[C@H](O)[C@H]%16O)O[C@@H]%15CSCCC(O)=O)O[C@@H]%14CSCCC(O)=O)O[C@@H]%13CSCCC(O)=O)O%10)=O)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
印地语: InChI=1S/C14H18FN3O4.ClH/c1-9(20)17-7-11-8-18(14(21)22-11)10-2-3-13(12(15)6-10)16-4-5-19;/h2-3,6,11,16,19H,4-5,7-8H2,1H3,(H,17,20);1H/t11-;/m0./s1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.